These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Evaluation of Volumetric Change of Intracerebral Hemorrhage in Patients Treated with Thrombolysis for Intraventricular Hemorrhage. Staub-Bartelt F; van Lieshout JH; Beez T; Kram R; Hänggi D; Beseoglu K Neurocrit Care; 2021 Apr; 34(2):529-536. PubMed ID: 32737761 [TBL] [Abstract][Full Text] [Related]
28. Recombinant tissue plasminogen activator in the treatment of intraventricular hemorrhage secondary to periventricular arteriovenous malformation before surgery: case report. Kumar K; Demeria DD; Verma A Neurosurgery; 2003 Apr; 52(4):964-8; discussion 968-9. PubMed ID: 12657195 [TBL] [Abstract][Full Text] [Related]
29. The long-term effect of recombinant tissue-plasminogen-activator (rt-PA) on edema formation in a large-animal model of intracerebral hemorrhage. Thiex R; Küker W; Müller HD; Rohde I; Schröder JM; Gilsbach JM; Rohde V Neurol Res; 2003 Apr; 25(3):254-62. PubMed ID: 12739233 [TBL] [Abstract][Full Text] [Related]
30. Stereotactic puncture and lysis of spontaneous intracerebral hemorrhage using recombinant tissue-plasminogen activator. Schaller C; Rohde V; Meyer B; Hassler W Neurosurgery; 1995 Feb; 36(2):328-33; discussion 333-5. PubMed ID: 7731513 [TBL] [Abstract][Full Text] [Related]
31. Systemic hematologic status following intraventricular recombinant tissue-type plasminogen activator for intraventricular hemorrhage: the CLEAR IVH Study Group. Herrick DB; Ziai WC; Thompson CB; Lane K; McBee NA; Hanley DF Stroke; 2011 Dec; 42(12):3631-3. PubMed ID: 21940973 [TBL] [Abstract][Full Text] [Related]
32. Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship. Wang YC; Lin CW; Shen CC; Lai SC; Kuo JS J Neurol Sci; 2002 Oct; 202(1-2):35-41. PubMed ID: 12220690 [TBL] [Abstract][Full Text] [Related]
33. [Effectiveness and safety of intraventricular fibrinolysis in secondary intraventricular hemorrhages (a prospective, randomized study)]. Gubucz I; Kakuk I; Major O; Szegedi N; Barsi P; Pánczél G; Varga D; Ovary C; May Z; Ricsói G; Kenéz J; Szilágyi G; Nagy Z Orv Hetil; 2004 Aug; 145(31):1609-15. PubMed ID: 15384858 [TBL] [Abstract][Full Text] [Related]
34. Systemic hemostasis with recombinant-activated factor VII followed by local thrombolysis with recombinant tissue plasminogen activator in intraventricular hemorrhage. Ionita CC; Ferrara J; McDonagh DL; Grossi P; Graffagnino C Neurocrit Care; 2005; 3(3):246-8. PubMed ID: 16377837 [TBL] [Abstract][Full Text] [Related]
35. Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis? Whitelaw A; Mowinckel MC; Abildgaard U Acta Paediatr; 1995 Aug; 84(8):933-6. PubMed ID: 7488820 [TBL] [Abstract][Full Text] [Related]
37. Fibrinolytic treatment of intraventricular haemorrhage preceding surgical repair of ruptured aneurysms and arteriovenous malformations. Mayfrank L; Rohde V; Gilsbach JM Br J Neurosurg; 1999 Apr; 13(2):128-31. PubMed ID: 10616579 [TBL] [Abstract][Full Text] [Related]
38. Single versus bilateral external ventricular drainage for intraventricular fibrinolysis using urokinase in severe ventricular haemorrhage. Du B; Wang J; Zhong XL; Liang J; Xiang W; Chen D; Lv W; Shan AJ Brain Inj; 2014; 28(11):1413-6. PubMed ID: 24830742 [TBL] [Abstract][Full Text] [Related]
39. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. Akdemir H; Selçuklu A; Paşaoğlu A; Oktem IS; Kavuncu I Neurosurg Rev; 1995; 18(2):95-100. PubMed ID: 7478022 [TBL] [Abstract][Full Text] [Related]